Logo image of CLCO.CA

CULICO METALS INC (CLCO.CA) Stock Fundamental Analysis

TSX-V:CLCO - TSX Venture Exchange - CA22989Q1019 - Common Stock - Currency: CAD

0.195  +0.01 (+2.63%)

Fundamental Rating

2

Overall CLCO gets a fundamental rating of 2 out of 10. We evaluated CLCO against 797 industry peers in the Metals & Mining industry. CLCO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLCO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CLCO had negative earnings in the past year.
CLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFCLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

CLCO has a Return On Assets (-27.48%) which is in line with its industry peers.
The Return On Equity of CLCO (-31.17%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -27.48%
ROE -31.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLCO.CA Yearly ROA, ROE, ROICCLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CLCO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLCO.CA Yearly Profit, Operating, Gross MarginsCLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024

More info and screens

5

2. Health

2.1 Basic Checks

CLCO.CA Yearly Shares OutstandingCLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2024 20M 40M 60M 80M
CLCO.CA Yearly Total Debt VS Total AssetsCLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 7.57 indicates that CLCO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.57, CLCO is in the better half of the industry, outperforming 69.51% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that CLCO is not too dependend on debt financing.
The Debt to Equity ratio of CLCO (0.08) is worse than 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 7.57
ROIC/WACCN/A
WACCN/A
CLCO.CA Yearly LT Debt VS Equity VS FCFCLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 0 2M 4M 6M 8M

2.3 Liquidity

CLCO has a Current Ratio of 10.33. This indicates that CLCO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.33, CLCO belongs to the top of the industry, outperforming 85.70% of the companies in the same industry.
A Quick Ratio of 10.33 indicates that CLCO has no problem at all paying its short term obligations.
CLCO has a better Quick ratio (10.33) than 85.82% of its industry peers.
Industry RankSector Rank
Current Ratio 10.33
Quick Ratio 10.33
CLCO.CA Yearly Current Assets VS Current LiabilitesCLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLCO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLCO.CA Price Earnings VS Forward Price EarningsCLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLCO.CA Per share dataCLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLCO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CULICO METALS INC

TSX-V:CLCO (8/8/2025, 7:00:00 PM)

0.195

+0.01 (+2.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.72%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap0
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.48%
ROE -31.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.33
Quick Ratio 10.33
Altman-Z 7.57
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A